Feigal moves to head up CDRH (US Center for Devices and Radiological Health) after role as senior official at CBER (Center for Biologics Evaluation and Research)
This article was originally published in Clinica
In an paradoxical twist for the medical device industry, the new director of the US FDA's Center for Devices and Radiological Health (CDRH) is David Feigal, a top-ranking official at the FDA's Center for Biologics Evaluation and Research (CBER).
You may also be interested in...
The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.